Hsp27 decreases inclusion body formation from mutated GTP-cyclohydrolase I protein  by Chiou, Yu-Wei et al.
Available online at www.sciencedirect.com
a 1782 (2008) 169–179
www.elsevier.com/locate/bbadisBiochimica et Biophysica ActHsp27 decreases inclusion body formation from mutated
GTP-cyclohydrolase I protein
Yu-Wei Chiou a,b, Wuh-Liang Hwu c, Yu-May Lee a,b,⁎
a Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan
b Institute of Biochemical Sciences, National Taiwan University, Taipei, Taiwan
c Department of Pediatrics and Medical Genetics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
Received 11 July 2007; received in revised form 18 December 2007; accepted 20 December 2007
Available online 14 January 2008
Abstract
GTP cyclohydrolase I (GCH), an oligomeric protein composed of 10 identical subunits, is required for the synthesis of neurotransmitters;
mutations in GCH are associated with dopa-responsive dystonia (DRD) and hyperphenylalaninemia. Mutated GCH proteins are unstable and
prone to dominant-negative effect. We show herein that expression of the GCH mutant GCH-201E or the splicing variant GCH-II caused
intracellular inclusion bodies. When Hsp27 was expressed together with the GCH mutants, Hsp27 expression decreased the formation of inclusion
bodies by GCH (as assessed by immunofluorescence) and decreased the amount of insoluble GCH mutant proteins (as assessed by Western blot).
Transfection of pcDNA-Hsp27-S3D, a phosphorylation-mimicry Hsp27 mutant, was more effective at the mutated GCH proteins than transfection
with pcDNA-Hsp27, but okadaic acid, a phosphatase inhibitor, enhanced the effect of pcDNA-Hsp27. Hsp27-S3D also abolished the dominant-
negative action of GCH-II. The mutated GCH proteins interacted with the wild-type GCH protein; the inclusion bodies were positive for
lysosomal marker LAMP1, soluble in 2% SDS, and were not ubiquitinated. Phophorlyated Hsp27 also decreased the inclusion body formation by
the huntingtin polyglutamines. Therefore, diseases involving mutated oligomeric proteins would be manageable by chaperone therapies.
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GTP cyclohydrolase I (GCH; EC 3.5.4.16) [1] is a homo-
decameric protein [2,3], and mutations of GCH gene are as-
sociated with a wide range of clinical conditions, ranging from
benign dopa-responsive dystonia (DRD) to malignant hyper-
phenylalaninemia [4–7]. The oligomeric quaternary structure
of GCH seems to amplify its molecular defects and cause
phenotype variabilities. Previously we have shown that muta-
ted GCH proteins are unstable and prone to dominant-negative
effect [4,5]. In this study, we show that expression of GCH-201EAbbreviations: Hsp, heat shock protein; GCH, GTP-cyclohydrolase I; BHK
cells, baby hamster ovary cells; DRD, dopa-responsive dystonia
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doi:10.1016/j.bbadis.2007.12.010(a mutation causing DRD) or splicing variant GCH-II (which
encodes a shorter peptide) in baby hamster kidney (BHK) cells
causes the formation of prominent punctate cytoplasmic inclu-
sion bodies in immunofluorescence staining.
Protein aggregates are involved in neurodegenerative disea-
ses including Alzheimer disease, Parkinson disease, Huntington
disease, and prion diseases [8]. The aggregates consist of frag-
ments of mutated proteins like the polyglutamines in Hunting-
ton disease, or the aberrantly cleaved amyloid beta protein in
Alzheimer disease [8]. These polypeptides have a highly abnormal
conformation, which prevents normal folding, and therefore form
aggregates through polymerization. For example, polyglutamines
form pleated sheets of beta-strands held together by hydrogen
bonds between their amides, and associate irreversibly into oligo-
mers firmly interlocked by either strand- or domain-swapping [9]
or covalent bonds [10]. The aggregates themselves, or early steps in
the cascade, cause toxicity and subsequent death of the cells.
Fig. 1. GCH-II and GCH-201E form cytoplasmic inclusion bodies. Immunofluorescence staining of BHK cells expressing pCMV-A16-GCH-WT (WT), pCMV-GCH-
201E (G201E), or pCMV-GCH-II (GCH-II). The left panel shows GCH staining (green) and the right panel shows both GCH and 4′,6-diamidino-2-phenylindole
(DAPI) staining (blue). DAPI stains the nuclei. Both GCH-G201E and GCH-II form small punctate cytoplasmic inclusion bodies.
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known as cellular machineries against the accumulation of
damaged proteins during stress. Hsp70 and other chaperones
also protect partially synthesized peptides when they emerge
from the ribosomes [11,12]. Overexpression of chaperones has
been evaluated as a therapeutic strategy to promote proper
folding or degradation of misfolded proteins [13,14]. It has
been shown that chaperones HDJ-2/HSDJ [13], Hsp40 and
Hsp70 [15], and MRJ [16] modulate polyglutamine pathoge-
nesis. Chaperonin TRiC promotes the assembly of polygluta-
mine expansion proteins into nontoxic oligomers [17]. Actually,
upregulation of Hsp70 may be an intrinsic cellular response
against the neuronal degeneration mediated by the huntingtin
mutant [18].
In this study, we tested the effect of small heat shock pro-
tein Hsp27 [19] on GCH inclusion body formation. We de-
monstrated that Hsp27, in its phosphorylated form, effectivelyprevented GCH-201E- and GCH-II-mediated formation of in-
clusion bodies, so chaperone therapy could be helpful in these
conditions.
2. Materials and methods
2.1. Vectors and chemicals
Expression vectors pCMV-A16-GCH-WT (GCH-WT), pCMV-GCH-II
(GCH-II), and pCMV-GCH-201E (GCH-201E) have been described previously
[4,5]. N-terminal AGP/EBP A16 epitope was added to the GCH proteins for the
convenience of detection, and the A16-tagged GCH proteins have molecular
weights higher than the HA-tagged or untagged GCH proteins [20]. A rabbit
antiserum (anti-N20) against the A16 epitope was developed in house. pcDNA3-
Hsp27 (Hsp27) and pcDNA3-Hsp27-S3D (Hsp27-S3D) were gifts from Dr.
Gaestel [21]. Replacing serine 15, 78, and 82 by aspartate, Hsp27-S3D mimics
Hsp27 phosphorylation [21]. Okadaic acid was obtained from Sigma Chemical
Company (St Louis,Mo, USA). A polyglutamine tract with alternating CAG/CAA
repeats, encoding 71 glutamines (71Q-GFP), was inserted into the context of the
Fig. 2. Hsp27-S3D reduces GCH-II inclusion body formation. BHK cells were transfected with pCMV-A16-GCH-WT (A16-GCH) or pCMV-GCH-II (GCH-II), with
or without pcDNA3-Hsp27 (Hsp27) or pcDNA3-Hsp27-S3D (Hsp27-S3D). Cells were stained with both anti-GCH (left column) and anti-Hsp27 (middle column)
antibodies. Images were captured by confocal microscope. The images for GCH and Hsp27 staining were merged on the right column.
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USA). pcDNA3-HA-ubiquitin (HA-Ub) has been described by Ebisawa et al [22].
2.2. Cells and treatments
Baby hamster kidney (BHK) or NIH293 cells were cultured in DMEM
supplemented with 10% fetal calf serum. Transfection was performed by us-
ing the calcium phosphate method [23] or LipofectAmine 2000 (Invitrogen,Carlsbad, California USA). Forty hours after transfection, cells were disrupted
by sonication in phosphate-buffered saline with 2.5 mM EDTA. The supernatant
(Sup) and pellet (Pellet) fractions were separated by centrifugation 12,000 ×g for
10 min at 4 °C in a microcentrifuge. The 1× gel-loading buffer contained either
2% SDS and 5 M urea (urea gel-loading buffer, for most of the experiments
unless specified), or 2% SDS and 10% glycerol (glycerol gel-loading buffer).
The anti-GCH antibody was raised in rabbit previously [4]. Both anti-Hsp27 and
anti-phospho-Hsp27 (Ser78) were obtained from Stressgen (Victoria, Canada).
Fig. 3. Okadaic acid enhances the effect of Hsp27 on decreasing GCH-II inclusion bodies. BHK cells were transfected with pCMV-GCH-II (GCH-II) alone (A), or
together with pcDNA3-Hsp27 (Hsp27) (B, D, E, and F) or pcDNA3-Hsp27-S3D (Hsp27-S3D) (C) followed by immunofluorescence staining with anti-GCH. Cells
were treated with 40 to 100 nM of okadaic acid (OA) in panels D, E, and F.
Fig. 4. Hsp27-S3D increases the expression of wild-type GCH. (A) BHK cells were transfected with pCMV-A16-GCH-WT (A16-GCH), with or without pcDNA3-
Hsp27 (Hsp27) or pcDNA3-Hsp27-S3D (Hsp27-S3D). Western blot analyses were performed with anti-GCH (GCH) or anti-tubulin (Tubulin) on the supernatant
fraction of the cell lysate. The quantities of plasmid used in the assays were either 0.6 μg or 1.2 μg. (B) Quantification of the results. The films were converted into
digital images by a desk scanner. The signal intensities were quantified by using a densitometry software, and expressed by comparing to the GCH-only experiments.
The lines above the bars represent one standard deviation calculated from 3 or more experiments.
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Fig. 5. Phospho-Hsp27 decreases insoluble GCH proteins and increases soluble GCH-II protein. Western blot analyses were performed on BHK cells transfected
with pCMV-GCH-201E (GCH-201E) or pCMV-GCH-II (GCH-II), with or without pcDNA3-Hsp27 (Hsp27) or pcDNA3-Hsp27-S3D (Hsp27-S3D). For some
experiments, cells were further treated with 100 nM okadaic acid (OA). (A) Effect of Hsp27 on GCH-II. Western blots were performed with either anti-GCH (GCHII),
anti-Hsp27 (Hsp27), anti-phospho-Hsp27 (Phospho-Hsp27), or anti-tubulin (Tubulin) on either the supernatant (Sup, or when not indicated) or pellet (Pellet) fraction.
Lane 1 was a non-transfection control. (B) Effect of Hsp27 on GCH-201E. Western blot analyses were performed with anti-GCH (GCH-201E), anti-Hsp27 (Hsp27),
or anti-tubulin (Tubulin).
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were visualized by using the Western Lightning kit (NEN, Boston, Mass, USA).
For immunoprecipitation experiments, cells were sonicated in 200 μl Tris–EDTA
buffer containing 1% Triton X-100 and centrifugated at 14,000 rpm for 5 min,
and after that 12 μl supernatant was loaded as input. Another 180 μl supernatant
was incubated with HA beads for 2 h at 4 °C with continuous agitation. After
wash for 3 to 4 times with the lysis buffer, samples were boiled in urea gel-
loading buffer and subjected for Western blot analysis with anti-N20 or anti-HA
to visualize GCH or ubiquitinated proteins.
For immunofluorescence staining, cells grown on cover slips were fixed
by 4% paraformaldehyde, and were permeabilized by 0.1% triton X-100. The
secondary antibodies were either FITC-labeled anti-rabbit or Rodamin-labeled
anti-mouse Ig. Slides were mounted in 50% glycerol and were visualized by
fluorescence microscope or confocal microscope (Carl Zeiss, LSM510 Laser
scanning confocal microscope). Okadaic acid was dissolved in 10% DMSO as a
10 μM stock. The working concentrations of okadaic acid were from 20 nM to
100 nM. Okadaic acid was added to the medium 16 h after transfection.
2.3. GCH cross-linking and filter retardation assay
Both wild-type GCH, GCH-II, and GCH-201E were cloned into pGEX-4
vector (GE Healthcare, Piscataway, NJ, USA) and expressed in E. coli as GSTfusion proteins. The expressed GCH proteins were purified by GST isolation
according to the manufacturers' instruction (GE Healthcare, Piscataway, NJ,
USA). GCH cross-linking was performed in 10 μL of 1× PBS, 2.5 mM EDTA
buffer (pH 7.0) at a 7 mg/mL protein concentration. The protein mixture reacted
with disuccinimidyl suberate (DSS, Pierce, Rockford, Ill, USA) at concentrations
from 0.025 mM to 2 mM and was incubated at room temperature for 30 min.
A 35-mM glycine buffer was used to terminate the reactions by incubation for
15 min at room temperature. The cross-linked protein mixture was resolved by
electrophoresis on gradient polyacrylamide gels in the presence of SDS. After
electrophoresis, protein was transferred onto nitrocellulose membrane for Wes-
tern blot analysis.
For filter retardation assay [24], the cell lysates were prepared in either PBS
or 2% SDS, and were filtered through a cellulose acetate membrane with 0.2 μm
pore size (Schleicher and Schuell, Keene, NH, USA) by the Bio-Dot apparatus
(Bio-Rad, Hercules, CA, USA). Western blot analysis was then performed with
anti-GCH.
2.4. Analysis of polyglutamine aggregation
BHK cells were transiently transfected with 71Q-GFP alone or in combina-
tion with pcDNA3-Hsp27 or pcDNA3-Hsp27-S3D. Expression of 71Q-GFP
induced cytoplasmic inclusion bodies were visualized under fluorescence
Fig. 6. Disuccinimidyl suberate (DSS) cross-linking assay. (A) Cross-linking of
recombinant wild-type GCH protein with DSS at concentrations from 0.125 to
2 mM. Lane 1: untransfected control. Wild-type GCHwasmonomeric or dimeric
in urea gel-loading buffer (Lane 2). With increasing concentration of DSS, GCH
oligomers appeared (Lanes 3–7). (B) DSS cross-linking of GCH-201E and
GCH-II. The input of GCH-II was less, but the formation of dimer and trimer was
similar to those formed by thewild-typeGCHprotein. GCH-201E could not form
any complex structures, and remained in monomeric form.
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counting ten 200× fields for each sample. The values were expressed asmean±SD.
Statistical analysis was performed using the unpaired t-test, with pb0.05 con-
sidered statistically significant.3. Results
3.1. Hsp27-S3D decreases inclusion body formation by
mutated GCH proteins
We have previously demonstrated that both GCH-201E
and GCH-II were unstable [4,5,25]. Here we showed that when
GCH proteins were expressed in BHK cells, wild-type GCH
(pCMV-A16-GCH-WT) gave a homogeneous cytoplasmic im-
munofluorescence stain, while both GCH-201E and GCH-II
expression resulted in punctate cytoplasmic inclusion bodies
(Fig. 1).
In order to determine if Hsp27 has an effect on the GCH
inclusion body formation, we cotransfected expression vectors
for both GCH and Hsp27 in BHK cells. We found that co-transfection of pcDNA-Hsp27 or pcDNA-Hsp27-S3D did not
alter the staining pattern of wild-type GCH, although the inten-
sity of the stain was stronger when pcDNA-Hsp27-S3D was
cotransfected (Fig. 2, A and B). Cotransfection of pcDNA-Hsp27
did not alter inclusion body formation from GCH-II (Fig. 2C),
but cotransfection of pcDNA-Hsp27-S3D changed the punctate
GCH-II stain into a homogeneous pattern similar to that from the
wild-type GCH (Fig. 2D).
3.2. Phosphorylation of Hsp27 is necessary for its function on
GCH mutants
To further determine whether the phosphorylation of Hsp27
is necessary for its effect on GCH mutant proteins, we utilized
okadaic acid, an inhibitor of phosphatase PP2A which depho-
sphorylates phospho-Hsp27 [26], in the experiments. In immu-
nofluorescence staining, we demonstrated that okadaic acid at
concentrations 60 to 100 nM effectively decreased the number of
GCH-II inclusion bodies in BHK cells (Fig. 3).
3.3. Hsp27 decreases insoluble GCH mutant proteins
We further usedWestern blot analysis to examine the effect of
Hsp27. We first confirmed our observation from the immuno-
fluorescence staining experiments, i.e., Hsp27-S3D, but not
Hsp27, increased the quantity of wild-type GCH protein (Fig. 4,
A and B, p=0.01). In order to show that the effect of Hsp27 was
not due to the induction of other chaperones, we measured the
expressions of Hsp60, Hsp70, and Hsp90 in the experiments.
Although these heat shock proteins were slightly induced by
Hsp27 overexpression, the induction was lower with pcDNA-
Hsp27-S3D which showed higher effects toward GCH (data not
shown). Therefore, the effect of Hsp27-S3D on GCH mutant
proteins should not be due to the induction of other heat shock
proteins.
In BHK cells expressing GCH-II, cotransfection of pcDNA-
Hsp27-S3D or pcDNA-Hsp27 plus okadaic acid decreased the
amount of insoluble GCH (Fig. 5A, Pellet). Okadaic acid treat-
ment dramatically increased the quantity of phospho-Hsp27
in cells (Fig. 5A, phospho-Hsp27). pcDNA-Hsp27 plus oka-
daic acid also increased the quantity of soluble GCH-II, but
pcDNA-Hsp27 itself or pcDNA-Hsp27-S3D was less effective
(Fig. 5A, Sup). In BHK cells expressing GCH-201E, cotransfec-
tion with pcDNA-Hsp27, pcDNA-Hsp27-S3D, or pcDNA-Hsp27
plus okadaic acid decreased the amount of GCH in the pel-
let fraction, but again Hsp27 was less effective (Fig. 5B, Pellet).
GCH-201E was not visible in the supernatant (data not shown).
3.4. Interaction between the wild-type and mutant GCH
proteins and the dominant-negative effect
We first used the DSS cross-linking assay to evaluate the
quaternary structures of GCH-201E and GCH-II. As shown in
Fig. 6, E. coli-produced recombinant wild-type GCH was mono-
meric or dimeric in urea gel-loading buffer (Fig. 6A, Lane 2). With
increasing concentration of DSS, GCH oligomers appeared in the
gel. Recombinant GCH-II could be cross-linked in a similar way
Fig. 7. Interactions between the wild-type and mutant GCH proteins and the dominant-negative effect. (A) Both A16-GCH-WT, A16-GCH-201E, A16-GCH-II, and
HA-GCH-WTwere expressed in NIH293 cells. The crude cell lysates were immunoprecipitated (IP) with anti-HA, and then Western blots (IB) were done with either
anti-N20 or anti-HA. The figures show that both mutant GCH proteins can be brought down by wild-type GCH. (B) BHK cells were transfected with pCMV-A16-
GCH-WT (A16-GCH) alone, or together with pCMV-GCH-II (GCH-II), pcDNA3-Hsp27 (Hsp27), or pcDNA3-Hsp27-S3D (Hsp27-S3D). Western blot analyses were
performed with either anti-GCH (GCH) or anti-tubulin (Tubulin) on the supernatant fraction of the cell lysate. GCH-II was barely visible in the study and was omitted
from the picture.
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nomers throughout the experiments (Fig. 6B, right panel). This
might explain why we were not able to bring GCH-201E into the
soluble fraction.
We next approached the interaction between the wild-type
and mutant GCH proteins by coexpression studies in NIH293
cells. We demonstrated that in NIH293 cells when we expressed
the HA-tagged wild-type GCH protein together with either
A16-tagged GCH-201E or GCH-II, the mutated GCH proteins
could be precipitated by anti-HA (Fig. 7A). This proves the
interaction between the wild-type and mutated GCH proteins,
even though GCH-201E itself might not be able to form stable
oligomers. This result also supports our previous observation
for the dominant-negative effect of the mutated GCH proteins
where protein–protein interaction should be required.
We then tested whether Hsp27 would alter the dominant-
negative effect of the mutated GCH proteins. Cotransfection
of pCMV-GCH-II decreased the expression of wild-type GCH
in BHK cells (Fig. 7B, lanes 1–4). The addition of Hsp27, but
more effectively Hsp27-S3D, decreased the dominant-nega-
tive effect of GCH-II in a dose-dependent manner (Fig. 7B,
lanes 5–10). Therefore both GCH-II and GCH-201E interact
with their wild-type counter part, which could explain the do-
minant-negative effect, and the complex phenotypes and in-
heritance of the associated diseases.3.5. The nature of the inclusion bodies
We first used the filter retardation assay to estimate the sizes
of the GCH mutant proteins in the pellet fraction of the cells.
Cell lysates were prepared in either PBS or 2% SDS, and were
filtered through a 0.2 μm membrane (Schleicher and Schuell)
by a dot blot apparatus. After washing with PBS, Western blot
analysis was performed with anti-GCH. The 71Q-GFP aggre-
gation was used as a control, and the result showed that 71Q-
GFP was not soluble in 2% SDS and was retained on the
filter (Fig. 8A, A5 and B5) [24]. GCH mutant proteins, how-
ever, were completely solubilized by 2% SDS (Fig. 8A, B3 for
GCH-II, and A4 and B4 for GCH-201E). GCH proteins dot-
ted on nitrocellulose paper (NC) showed the presence of the
proteins (Fig. 8A, A1 for GCH-II and B1 for GCH-Wt). It is
interesting that, wild-type GCH, thought stayed in the super-
natant after sonication of the cell in PBS, could not pass the
filter in PBS (A2). It may be due to the formation of multiple
protein complexes.
We therefore changed the urea gel-loading buffer (2% SDS
and 5 M urea) to glycerol gel-loading buffer (2% SDS) in Wes-
tern blot analysis. The results showed that both GCH-II (Fig. 8B,
lanes 2, 4, 6, and 8, white arrows) and GCH-WT (lanes 10 and
12, black arrows) contained oligomeric structures when glycerol
gel-loading buffer was used. Either GCH-II in the cell pellets
Fig. 8. Structure and solubility of the GCHmutant proteins. Both GCH-WT, GCH-II and GCH-201E were expressed in BHK cells. Cell fractions used were: GCH-WT,
Supernatant (Sup); GCH-II, Sup and Pellet; GCH-201E, Pellet. (A) Filter retardation assay. Cell lysates were prepared in either PBS or 2% SDS, and were filtered
through a 0.2 μm membrane (Lanes 2–5) or NC membrane (Lane 1) by a dot blot apparatus. Western blot analysis was performed with anti-GCH. A1–2: GCH-II in
PBS; B1–2: GCH-WT in PBS; A3: GCH-II in SDS; B3: GCH-WT in SDS; A4 and B4: GCH-201E in SDS; A5 and B5: 71Q-GFP in SDS. (B) Western blot analysis of
the GCH proteins. Samples were prepared in either urea gel-loading buffer (odd number lanes) or glycerol gel-loading buffer (even number lanes). The white arrows
indicate GCH-II monomer and oligomers; the black arrows indicate GCH-WT monomer and oligomers; the stars indicate cross-reacting materials.
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Hsp27-S3D revealed the same oligomerization as the wild-type
GCH protein.
Since the mutated GCH proteins were soluble in SDS,
which is different from the aggregated proteins formed by
either polyglutamines or amyloid protein, we asked if the mu-
tated GCH proteins would be within lysosomes. When BHK
cells expressing GCH-201E were stained for both the lysoso-
mal marker LAMP1 and GCH, we could see that the two stains
colocalize quite well (Fig. 9, upper panel, A–C). Because
Hsp27 was not colocalized with GCH-II (Fig. 2C), Hsp27 did
not follow the GCH proteins to the lysosomes. The mutated
GCH protein (GCH-201E) was also not ubiquitinated (Fig. 9,
lower panel).
3.6. Hsp27 decreases inclusion body formation from
polyglutamines
Although the mutated GCH proteins did not have the
same character as the polyglutamine aggregations, we still
wanted to see the action of Hsp27 on the polyglutamines. The
results showed that expression of an elongated huntingtin
polyglutamine tract (71Q-GFP) in BHK cells produced pro-
minent cytoplasmic inclusion bodies (Fig. 10A). Coexpres-
sion of pcDNA-Hsp27-S3D (p=0.011) and pcDNA-Hsp27
(p=0.012) decreased the percentage of cells showing poly-glutamine inclusion bodies, but pcDNA-Hsp27-S3D was more
effective (p=0.018) (Fig. 10B).
4. Discussion
In this study, we demonstrated that mutated GCH proteins
form intracellular inclusion bodies. Although precipitation of
overexpressed proteins in cultured cells is occasionally seen,
this study is particularly interesting because GCH itself is
an oligomeric protein. A few cellular proteins oligomerize
or polymerize by themselves, and there are plenty of exam-
ples of abnormal precipitation of these proteins. In sickle
cell disease, the mutated β-globin chains tend to form long
chains or polymers [27]; in thalassemias, hemoglobin H (four
β chains) is unstable and tends to precipitate in red blood cells
and form characteristic inclusion bodies [28]. In Nemaline
myopathy, mutations in the human skeletal muscle α-actin
gene (ACTA1) causes the abnormal thread- or rod-like nema-
line bodies [29]. Actin is also one of the components in in-
clusion bodies of uterine leiomyomas [30], and abnormal
bundling and accumulation of F-actin mediates tau-induced
neuronal degeneration in vivo [31]. Therefore, cellular pro-
teins that naturally oligomerize may be prone to aggrega-
tion or precipitation upon unfavorable environments or
mutations. Diseases involving this phenomenon may be treated
by chaperone therapy, as in a recent paper that Hsp27-S3D
Fig. 9. Localization and ubiquitination of GCH-201E. Upper panel: BHK cells expressing pCMV-GCH-201E (GCH-201E) were stained by both anti-LAMP1 and anti-
GCH. Phase contrast-confocal microscopy studies were shown for LAMP1 (A), GCH-201E (B), and the merge picture (C). The GCH stain colocalizes with the
lysosome marker LAMP1. Lower panel: Ubiquitinization assay for GCH-201E. A16-GCH-201E and HA-Ub were expressed in NIH293 cells. Immunoprecipitation
(IP) was done by anti-HA, and Western blots (IB) were done with either anti-N20 or anti-HA. The results demonstrate that poly-ubiquitinated proteins (Poly-Ub) can
be precipitated by anti-HA, but GCH-201E (arrow) is not ubiquitinated.
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luble complex with denatured actin [32].
In the current study, we demonstrated that Hsp27 increases the
expression of the wild-type GCH protein, causes the appearance
of the soluble GCH-II protein, and decreases the quantities of
insoluble mutated GCH protein. Therefore, it is likely that Hsp27
improves the folding of mutated GCH proteins, so they can stay
in free cytosolic compartment. An enhancement in their degrada-
tion in the lysosomes is also possible, since we have previously
demonstrated that the lysosome inhibitors NHCl4 and PMSF
prevented the degradation of GCH-201E [4]. Although proteo-
some is the organelle responsible for protein degradation, and in
polyglutamine-related diseases the inclusion bodies are immuno-
positive for ubiquitin and proteasome subunits [13,33], a robust
activation of the neuronal lysosomal system has been recently
shown inAlzheimer andHuntington diseases [34,35]. SinceHsp27
is not associated with GCH in the inclusion bodies, it should act on
early stages of the maturation of the GCH protein. There have been
concerns regarding aggregation-targeting therapy since it is likelythat toxicity is due to the ongoing polymerization rather than the
stable aggregates [36]. Nevertheless, using Hsp27 as a therapeutic
molecule may not be a problem.
The role of phosphorylation in Hsp27 function has been a long
debate. Hsp27 belongs to a family of small heat shock proteins
[19] and protects cells from heat shock and oxidative stress
[19,37]. In unstressed cells, Hsp27 levels are generally low and
Hsp27 exists predominantly as a large oligomeric unit of up to
800 kDa. During the stress response, there is an increase in Hsp27
expression level which is preceded by a transient phosphorylation
of Hsp27 byMAPKAP kinase 2/3 on Ser-15, Ser-78, and Ser-82,
resulting in the redistribution of the large Hsp27 oligomer into
smaller tetrameric units [19,38]. The chaperonic activity of
Hsp27 was traditionally tested via the suppression of turbidity
formation from the thermal denaturation of citrate synthase, and
it has been shown that phosphorylation of Hsp27 decreased this
effect [21]. Some other studies employing this assay had similar
findings [39,40]. However, many recent studies have demon-
strated that stress stimulates Hsp27 phosphorylation in the heart,
Fig. 10. Phospho-Hsp27 decreases the formation of huntingtin polyglutamine inclusion bodies. BHK cells were transfected with 71Q-GFP (HT), with or without
Hsp27 (27) or Hsp27-S3D (S3D). (A) Aggregation formed in the cytoplasm could be visualized under fluorescence microscopy (left panel, 1000×), and inclusion
body-positive cells were counted in ten 200× fields (right panel) for each experiments. (B) The results were expressed as percentages of aggregation-positive cells. The
lines above the bars indicate one standard deviation.
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[41], ischemia [42], atrial fibrillation [43], or inflammation [44].
The interpretation of these data may be difficult because Hsp27
possesses anti-apoptotic activity [45]. However, non-phosphory-
lated Hsp27 was also thought to have anti-apoptotic function
[46,47], although exceptions were documented recently [48]. It is
possible that the mechanisms by which Hsp27 exerts its function
are more complex than what we thought and cannot be represented
solely by the turbidity test.More studies are required to clarify those
debates.
Although the mutated GCH proteins do not form tight SDS-
resistant aggregation as the polyglutamines [24], the similar
effects of phosphorylated Hsp27 on GCH and polyglutamines
indicate that Hsp27 helps the folding, to prevent the untoward
consequences of these mutated proteins. Recently, it starts to be
understood that the formation of protein aggregates is not a
single-step process. Nucleation-dependent polymerization has
been shown to be an essential component of amyloid-mediated
neuronal cell death [36]. The initial aggregates could be solu-
ble [49]. These initial aggregates or quasi-aggregates [50]
may be more important in the pathogenesis of the diseases.
Therefore, the application of Hsp27 in chaperone therapy
could be promising, as shown recently that Hsp27 protects
against α-synuclein-induced toxicity and aggregation [51]. The
oligomeric protein-associated diseases, though not necessary
associated with neurodegeneration, should also be good targets
for future chaperone therapy.
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